Skip to content
Disclosery

EXANE DERIVATIVES: GOOG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on GOOG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 609 GOOG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 609 shares
    Change vs previous 13F +95 shares

    0.77% of the 13F portfolio, value $1,331,995.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 514 shares
    Change vs previous 13F -39 shares

    0.4% of the 13F portfolio, value $1,435,607.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 553 shares
    Change vs previous 13F +50 shares

    0.39% of the 13F portfolio, value $1,600,207.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 503 shares
    Change vs previous 13F -16 shares

    0.33% of the 13F portfolio, value $1,340,704.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 519 shares
    Change vs previous 13F +66 shares

    0.32% of the 13F portfolio, value $1,359,753.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 453 shares
    Change vs previous 13F not available

    0.28% of the 13F portfolio, value $937,133.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).